A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients

Tekijä Tate, Sonya C., Sykes, Amanda K., Kulanthaivel, Palaniappan, Chan, Edward M., Turner, P. Kellie, Cronier, Damien M.
Julkaisussa Clin Pharmacokinet (2017)

SUMO Pathway Dependent Recruitment of Cellular Repressors to Herpes Simplex Virus Type 1 Genomes

Tekijä Cuchet-Lourenço, Delphine, Boutell, Chris, Lukashchuk, Vera, Grant, Kyle, Sykes, Amanda, Murray, Jill, Orr, Anne, Everett, Roger D.
Julkaistu 2011

PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

Tekijä Cuchet, Delphine, Sykes, Amanda, Nicolas, Armel, Orr, Anne, Murray, Jill, Sirma, Hüseyin, Heeren, Joerg, Bartelt, Alexander, Everett, Roger D.
Julkaistu 2011

Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics

Tekijä Chigutsa, Emmanuel, Kambhampati, Siva Rama Prasad, Karen Sykes, Amanda, Posada, Maria M., van der Walt, Jan‐Stefan, Turner, P. Kellie
Julkaisussa CPT Pharmacometrics Syst Pharmacol (2020)

A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers

Tekijä Zhang, Jian, Yang, Nong, Ji, Dongmei, Shen, Weina, Li, Wenhua, Han, Rubing, Wang, Ning, Tao, Haoxun, Chapman, Sonya C., Sykes, Amanda K., Zhang, Wanli, Hu, Xichun
Julkaisussa Target Oncol (2021)

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

Tekijä Simon, George R., Ilaria, Robert L., Sovak, Mika A., Williams, Charles C., Haura, Eric B., Cleverly, Ann L., Sykes, Amanda K., Wagner, Margaret M., de Alwis, Dinesh P., Slapak, Christopher A., Miller, Mary A., Spriggs, David R.
Julkaistu 2011